search
Back to results

Evaluation of a New Biocompatible Pressure Equalizing Tube

Primary Purpose

Otitis Media

Status
Withdrawn
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
PE tube with Duckbill Valve
Sponsored by
University of California, Irvine
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Otitis Media focused on measuring middler ear infection

Eligibility Criteria

undefined - undefined (Child, Adult, Older Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  1. Male/ female at all age- newborn to adult.
  2. Non- pregnant woman.
  3. Diagnose of middle ear infection and plan for surgery procedure

Exclusion Criteria:

  1. Pregnant woman
  2. Incompetent adults (i.e. individuals with cognitive impairment)
  3. Presence of immunodeficiency; cystic fibrosis; sickle cell disease;
  4. Another major systemic disease
  5. Congenital malformation of the external, middle, or inner ear
  6. Sensorineural hearing loss; otoneurologic disease
  7. History of prior ear surgery such as tympanoplasty, tympanomastoidectomy, or mastoidectomy; cholesteatoma; chronic mastoiditis; intratemporal or intracranial suppurative complications of otitis media
  8. Use of ototoxic medication (except topical use)

Sites / Locations

  • UCIMC

Arms of the Study

Arm 1

Arm Type

Experimental

Arm Label

PE tube with Duckbill Valve

Arm Description

PE tube with Duckbill Valve

Outcomes

Primary Outcome Measures

Pressure-equalizing tube with Duckbill Valve stop air and water passage during middle ear infection treatment

Secondary Outcome Measures

Full Information

First Posted
January 14, 2013
Last Updated
October 28, 2022
Sponsor
University of California, Irvine
Collaborators
Beckman Laser Institute University of California Irvine
search

1. Study Identification

Unique Protocol Identification Number
NCT01775709
Brief Title
Evaluation of a New Biocompatible Pressure Equalizing Tube
Official Title
Evaluation of a New Biocompatible Pressure Equalizing Tube
Study Type
Interventional

2. Study Status

Record Verification Date
October 2022
Overall Recruitment Status
Withdrawn
Why Stopped
no participants enrolled
Study Start Date
July 2012 (undefined)
Primary Completion Date
September 2014 (Actual)
Study Completion Date
September 2014 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
University of California, Irvine
Collaborators
Beckman Laser Institute University of California Irvine

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Otitis media is the most common illness in children and 5% to 10% of their symptom cause by fluids in their middle ear . The OME can cause hearing loss included poor development of speech and poor communication. The surgical procedure is considered simple and relatively safe, but several complications may occur after Pressure Equalizing tube insertion. The most prevalent complications are otorrhea, biofilm and formation of retraction pockets. Otorrhea occurs in 30% to 83% of children with tube and is mainly due bacterial contamination of the middle ear either from external ear canal or impaired Eustachian tube. Swimming can facilitate the entry of bacteria into the middle ear from the ear canal through the PE tubes, and this assumption is reinforced by the statistically significant association between the rate of otorrhea and the non-utilization of ear plugs in children who swim (from 47% in children who used ear plugs to 56% in those who did not).
Detailed Description
The researcher at Beckman Laser Institute, University of California, Irvine, develops new medical tool device call biocompatible Pressure Equalizing tube which can stop air passage and pressure equalization instantly, and can prevents water into the middle ear cavity. evaluate and compare the efficacy of a biocompatible Pressure Equalizing tube that enables air passage and pressure equalization almost instantly, while prevents the entrance of fluids, specially water, into the middle ear cavity. The biocompatible Pressure Equalizing tube can reduce the rate of postoperative otorrhea,air passage between outside and middle ear cavity,prevents formation of retraction pockets in TM and swimming with lower risk of otorrhea.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Otitis Media
Keywords
middler ear infection

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Single Group Assignment
Masking
None (Open Label)
Allocation
N/A
Enrollment
0 (Actual)

8. Arms, Groups, and Interventions

Arm Title
PE tube with Duckbill Valve
Arm Type
Experimental
Arm Description
PE tube with Duckbill Valve
Intervention Type
Device
Intervention Name(s)
PE tube with Duckbill Valve
Intervention Description
PE tube with Duckbill Valve
Primary Outcome Measure Information:
Title
Pressure-equalizing tube with Duckbill Valve stop air and water passage during middle ear infection treatment
Time Frame
up to 6 months

10. Eligibility

Sex
All
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Male/ female at all age- newborn to adult. Non- pregnant woman. Diagnose of middle ear infection and plan for surgery procedure Exclusion Criteria: Pregnant woman Incompetent adults (i.e. individuals with cognitive impairment) Presence of immunodeficiency; cystic fibrosis; sickle cell disease; Another major systemic disease Congenital malformation of the external, middle, or inner ear Sensorineural hearing loss; otoneurologic disease History of prior ear surgery such as tympanoplasty, tympanomastoidectomy, or mastoidectomy; cholesteatoma; chronic mastoiditis; intratemporal or intracranial suppurative complications of otitis media Use of ototoxic medication (except topical use)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Elliot Botvinick, Ph.D.
Organizational Affiliation
Beckman Laser Institute, UCI
Official's Role
Principal Investigator
Facility Information:
Facility Name
UCIMC
City
Orange
State/Province
California
ZIP/Postal Code
92868
Country
United States

12. IPD Sharing Statement

Learn more about this trial

Evaluation of a New Biocompatible Pressure Equalizing Tube

We'll reach out to this number within 24 hrs